Gland Pharma Ltd | Scrip Code : 543245 | Quarter ending :December 2020 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 5 | 9,52,93,934 | 9,52,93,934 | 58.36 | 9,52,93,934 | 58.36 | 9,52,93,934 | 100.00 | 9,52,93,934 | - | - | - | (B) Public | 77,258 | 6,79,88,889 | 6,79,88,889 | 41.64 | 6,79,88,889 | 41.64 | 1,87,91,921 | 27.64 | 6,19,13,889 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 77,263 | 16,32,82,823 | 16,32,82,823 | 100.00 | 16,32,82,823 | 100.00 | 11,40,85,855 | 69.87 | 15,72,07,823 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|